Research highlights medication adherence challenges for former prisoners

As they studied two years of prison-inmate data, Laura Dague and a team of fellow health researchers noticed that one particular scenario kept cropping up.

Stanford president to resign after investigation finds he failed to ‘decisively and forthrightly’ correct research

In an abrupt turn, Stanford president and renowned neuroscientist Marc Tessier-Lavigne announced Wednesday that he will step down as the university’s leader. His resignation came

July 19, 2023

Apalutamide Makes Its Case in Biochemically Recurrent Nonmetastatic Prostate Cancer

A 1-year period of intensified androgen receptor blockade prolonged prostate-specific antigen progression-free survival (PSA-PFS) compared with androgen deprivation therapy (ADT) alone for patients with high-risk,

January 25, 2024

Advancements in neoantigen vaccines offer hope for personalized cancer therapy

The saga of cancer treatment is marked by a relentless pursuit of effectiveness against a disease characterized by complexity and adaptability.

August 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.